Clinical Trials
7
Active:0
Completed:0
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (50.0%)Phase 2
1 (16.7%)Phase 3
1 (16.7%)Phase 4
1 (16.7%)Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
Not Applicable
Not yet recruiting
- Conditions
- Parkinson Disease(PD)
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Alain Kaelin
- Target Recruit Count
- 30
- Registration Number
- NCT07097298
- Locations
- 🇨🇭
Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC, Lugano, Switzerland
Technical and Clinical Validation of the WPM-SEMG Prototype
Not Applicable
Recruiting
- Conditions
- Neuron Disease, Motor
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-09-04
- Lead Sponsor
- Alain Kaelin
- Target Recruit Count
- 70
- Registration Number
- NCT06584084
- Locations
- 🇨🇭
Neurocentro della Svizzera Italiana, Lugano, Switzerland
Clinical Relevance of the HD sEMG Signals in the Post-stroke Rehabilitation
Not Applicable
Recruiting
- Conditions
- Stroke
- First Posted Date
- 2023-05-09
- Last Posted Date
- 2024-01-16
- Lead Sponsor
- Alain Kaelin
- Target Recruit Count
- 40
- Registration Number
- NCT05849896
- Locations
- 🇨🇭
Istituto di Neuroscienze Cliniche della Svizzera Italiana, Lugano, Switzerland
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Alain Kaelin
- Target Recruit Count
- 48
- Registration Number
- NCT03977493
- Locations
- 🇨🇭
Inselspital - University Hospital Berne, Berne, Switzerland
🇨🇭Centre hospitalier universitaire vaudois (CHUV), Lausanne, Switzerland
🇨🇭Neurocentro della Svizzera Italiana, Lugano, Switzerland
Effect of Safinamide on Sleep Quality in Patients With Parkinson's Disease
Phase 4
Recruiting
- Conditions
- Idiopathic Parkinson's Disease (at Later Stage)
- Interventions
- First Posted Date
- 2019-05-30
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- Alain Kaelin
- Target Recruit Count
- 23
- Registration Number
- NCT03968744
- Locations
- 🇨🇭
Neurocenter of Southern Switzerland - Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland
News
No news found